The American Journal of Medicine
Volume 119, Issue 3 , Pages 248-254 , March 2006

Chronic Kidney Disease in Patients with Non–ST-Segment Elevation Acute Coronary Syndromes

  • Jin H. Han, MD

      Affiliations

    • Department of Emergency Medicine, University of Cincinnati School of Medicine, Cincinnati, Ohio
    • Corresponding Author InformationRequests for reprints should be addressed to Jin H. Han, MD, Vanderbilt University Medical Center, Department of Emergency Medicine, 703 Oxford House, Nashville, TN 37232.
    • ,
  • Abhinav Chandra, MD

      Affiliations

    • Department of Emergency Medicine, Duke University Medical Center, Durham, NC
    • ,
  • Jyotsna Mulgund, MS

      Affiliations

    • Duke Clinical Research Institute, Duke University Medical Center, Durham, NC
    • ,
  • Matthew T. Roe, MD, MHS

      Affiliations

    • Division of Cardiology, Duke University Medical Center, Durham, NC
    • Duke Clinical Research Institute, Duke University Medical Center, Durham, NC
    • ,
  • Eric D. Peterson, MD, MPH

      Affiliations

    • Division of Cardiology, Duke University Medical Center, Durham, NC
    • Duke Clinical Research Institute, Duke University Medical Center, Durham, NC
    • ,
  • Lynda A. Szczech, MD

      Affiliations

    • Division of Nephrology, Duke University Medical Center, Durham, NC
    • Duke Clinical Research Institute, Duke University Medical Center, Durham, NC
    • ,
  • Uptal Patel, MD

      Affiliations

    • Division of Nephrology, Duke University Medical Center, Durham, NC
    • Duke Clinical Research Institute, Duke University Medical Center, Durham, NC
    • ,
  • E. Magnus Ohman, MD

      Affiliations

    • University of North Carolina School of Medicine, Chapel Hill, NC
    • ,
  • Christopher J. Lindsell, PhD

      Affiliations

    • Institute of Health Policy and Health Services Research, University of Cincinnati School of Medicine, Cincinnati, Ohio
    • ,
  • W. Brian Gibler, MD

      Affiliations

    • Department of Emergency Medicine, University of Cincinnati School of Medicine, Cincinnati, Ohio

Received 1 January 2005 ,Revised 22 August 2005 ,Accepted 22 August 2005.

References 

  1. Herzog CA , Ma JZ , Collins AJ . Poor long-term survival after acute myocardial infarction among patients on long-term dialysis . N Engl J Med . 1998;339:799–805
  2. Beattie JN , Soman SS , Sandberg KR , et al.   Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction . Am J Kidney Dis . 2001;37:1191–1200
  3. Wright RS , Reeder GS , Herzog CA , et al.   Acute myocardial infarction and renal dysfunction (a high-risk combination) . Ann Intern Med . 2002;137:563–570
  4. Chertow GM , Normand SL , Silva LR , McNeil BJ . Survival after acute myocardial infarction in patients with end-stage renal disease (results from the cooperative cardiovascular project) . Am J Kidney Dis . 2000;35:1044–1051
  5. Freeman RV , Mehta RH , Al Badr W , et al.   Influence of concurrent renal dysfunction on outcomes of patients with acute coronary syndromes and implications of the use of glycoprotein IIb/IIIa inhibitors . J Am Coll Cardiol . 2003;41:718–724
  6. Shlipak MG , Heidenreich PA , Noguchi H , et al.   Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients . Ann Intern Med . 2002;137:555–562
  7. Walsh CR , O’Donnell CJ , Camargo CA , et al.   Elevated serum creatinine is associated with 1-year mortality after acute myocardial infarction . Am Heart J . 2002;144:1003–1011
  8. Anavekar NS , McMurray JJ , Velazquez EJ , et al.   Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction . N Engl J Med . 2004;351:1285–1295
  9. Santopinto JJ , Fox KA , Goldberg RJ , et al.   Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes (findings from the global registry of acute coronary events (GRACE)) . Heart . 2003;89:1003–1008
  10. Braunwald E , Antman EM , Beasley JW , et al.   ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction–summary article (a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina)) . J Am Coll Cardiol . 2002;40:1366–1374
  11. Levey AS , Green T , Kusek JW , et al.   A simplified equation to predict glomerular filtration rate from serum creatinine (a new prediction equation) . (Abstract) J Am Soc Nephrol . 2000;11:A0828
  12. Zeger SL , Liang KY , Albert PS . Models for longitudinal data (a generalized estimating equation approach) . Biometrics . 1988;44:1049–1060
  13. Foley RN , Parfrey PS , Sarnak MJ . Clinical epidemiology of cardiovascular disease in chronic renal disease . Am J Kidney Dis . 1998;32:S112–S119
  14. deFilippi C , Wasserman S , Rosanio S , et al.   Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis . JAMA . 2003;290:353–359
  15. Lowbeer C , Stenvinkel P , Pecoits-Filho R , et al.   Elevated cardiac troponin T in predialysis patients is associated with inflammation and predicts mortality . J Intern Med . 2003;253:153–160
  16. Hausberg M , Kosch M , Harmelink P , et al.   Sympathetic nerve activity in end-stage renal disease . Circulation . 2002;106:1974–1979
  17. McCullough PA , Nowak RM , Foreback C , et al.   Emergency evaluation of chest pain in patients with advanced kidney disease . Arch Intern Med . 2002;162:2464–2468
  18. Mezzano D , Tagle R , Panes O , et al.   Hemostatic disorder of uremia (the platelet defect, main determinant of the prolonged bleeding time, is correlated with indices of activation of coagulation and fibrinolysis) . Thromb Haemost . 1996;76:312–321
  19. McCullough PA , Sandberg KR , Borzak S , et al.   Benefits of aspirin and beta-blockade after myocardial infarction in patients with chronic kidney disease . Am Heart J . 2002;144:226–232
  20. Berger AK , Duval S , Krumholz HM . Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction . J Am Coll Cardiol . 2003;42:201–208
  21. Januzzi JL , Snapinn SM , DiBattiste PM , et al.   Benefits and safety of tirofiban among acute coronary syndrome patients with mild to moderate renal insufficiency (results from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) trial) . Circulation . 2002;105:2361–2366
  22. Reddan DN , O’Shea JC , Sarembock IJ , et al.   Treatment effects of eptifibatide in planned coronary stent implantation in patients with chronic kidney disease (ESPRIT Trial) . Am J Cardiol . 2003;91:17–21
  23. Spinler SA , Inverso SM , Cohen M , et al.   Safety and efficacy of unfractionated heparin versus enoxaparin in patients who are obese and patients with severe renal impairment (analysis from the ESSENCE and TIMI 11B studies) . Am Heart J . 2003;146:33–41
  24. Best PJ , Lennon R , Ting HH , et al.   The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions . J Am Coll Cardiol . 2002;39:1113–1119
  25. Bartholomew BA , Harjai KJ , Dukkipati S , et al.   Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification . Am J Cardiol . 2004;93:1515–1519
  26. Sadeghi HM , Stone GW , Grines CL , et al.   Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction . Circulation . 2003;108:2769–2775
  27. Keeley EC , Kadakia R , Soman S , et al.   Analysis of long-term survival after revascularization in patients with chronic kidney disease presenting with acute coronary syndromes . Am J Cardiol . 2003;92:509–514
  28. Rubenstein MH , Harrell LC , Sheynberg BV , et al.   Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era? . Circulation . 2000;102:2966–2972
  29. Szczech LA , Reddan DN , Owen WF , et al.   Differential survival after coronary revascularization procedures among patients with renal insufficiency . Kidney Int . 2001;60:292–299
  30. Herzog CA , Ma JZ , Collins AJ . Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes . Circulation . 2002;106:2207–2211
  31. Hemmelgarn BR , Southern D , Culleton BF , et al.   Survival after coronary revascularization among patients with kidney disease . Circulation . 2004;110:1890–1895
  32. Januzzi JL , Cannon CP , DiBattiste PM , et al.   Effects of renal insufficiency on early invasive management in patients with acute coronary syndromes (The TACTICS-TIMI 18 Trial) . Am J Cardiol . 2002;90:1246–1249
  33. Goldenberg I , Shechter M , Matetzky S , et al.   Oral acetylcysteine as an adjunct to saline hydration for the prevention of contrast-induced nephropathy following coronary angiography (A randomized controlled trial and review of the current literature) . Eur Heart J . 2004;25:212–218
  34. Merten GJ , Burgess WP , Gray LV , et al.   Prevention of contrast-induced nephropathy with sodium bicarbonate (a randomized controlled trial) . JAMA . 2004;291:2328–2334
  35. Apple FS , Murakami MM , Pearce LA , Herzog CA . Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease . Circulation . 2002;106:2941–2945
  36. Green TR , Golper TA , Swenson RD , et al.   Diagnostic value of creatine kinase and creatine kinase MB isoenzyme in chronic hemodialysis patients (a longitudinal study) . Clin Nephrol . 1986;25:22–27
  37. Fernandez JS , Sadaniantz BT , Sadaniantz A . Review of antithrombotic agents used for acute coronary syndromes in renal patients . Am J Kidney Dis . 2003;42:446–455
  38. Physicians’ Desk Reference . 58th ed.. Montvale, NJ: Thomson PDR; 2004;

 CRUSADE is funded by Millennium Pharmaceuticals, Inc., Cambridge, MA, and Schering Corporation, Kenilworth, NJ. Bristol-Myers Squibb (Plainsboro, NJ)/Sanofi Pharmaceuticals (New York, NY) Partnership provides additional funding support.

PII: S0002-9343(06)00003-9

doi: 10.1016/j.amjmed.2005.08.057

The American Journal of Medicine
Volume 119, Issue 3 , Pages 248-254 , March 2006

Article Tools

* Image Usage & Resolution